Peptron, Inc. (KOSDAQ:087010)
South Korea
· Delayed Price · Currency is KRW 285,000
+4,500 (1.60%)
At close: Dec 5, 2025
Peptron Revenue
Peptron had revenue of 1.60B KRW in the quarter ending September 30, 2025, with 172.26% growth. This brings the company's revenue in the last twelve months to 6.19B, up 157.24% year-over-year. In the year 2024, Peptron had annual revenue of 3.15B, down -5.68%.
Revenue (ttm)
6.19B
Revenue Growth
+157.24%
P/S Ratio
1,073.20
Revenue / Employee
n/a
Employees
n/a
Market Cap
6,645.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.15B | -189.71M | -5.68% |
| Dec 31, 2023 | 3.34B | -2.47B | -42.52% |
| Dec 31, 2022 | 5.81B | -810.52M | -12.24% |
| Dec 31, 2021 | 6.62B | 3.50B | 112.28% |
| Dec 31, 2020 | 3.12B | 1.32B | 73.26% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| HLB Co., Ltd. | 80.73B |